rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Suzanne Louise Topalian

Director

Company insider

Files Form 4 as: Director, Vir Biotechnology.

In numbers

Trades disclosed
4
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
27 Oct 2026
Last trade
27 Oct 2026
Last filed
28 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
VIR Vir BiotechnologyDirector · Biotechnology · last 27 Oct 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
27 Oct 2026filed 28 Oct 2026VIR Vir BiotechnologyBiotechnologySEC FORM 4 Code A—8,000 at $0.00filing
27 Oct 2026filed 28 Oct 2026VIR Vir BiotechnologyBiotechnologySEC FORM 4 Code A—4,731 at $0.00filing
27 Oct 2026filed 28 Oct 2026VIR Vir Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
27 Oct 2026filed 28 Oct 2026VIR Vir Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—9,462 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Vanina de VerneuilEVP, General Counsel, Corp Sec · EVP, General Counsel, Corp Sec at Vir Biotechnology, filing Form 4 there in the last year
Robert J. MoreDirector · Director at Vir Biotechnology, filing Form 4 there in the last year
Timothy CoughlinDirector · Director at Vir Biotechnology, filing Form 4 there in the last year
Janet NapolitanoDirector · Director at Vir Biotechnology, filing Form 4 there in the last year
Brent SabatiniSVP, Chief Accounting Officer · SVP, Chief Accounting Officer at Vir Biotechnology, filing Form 4 there in the last year